Extracellular vesicle miR-32 derived from macrophage promotes arterial calcification in mice with type 2 diabetes via inhibiting VSMC autophagy
(2022) 20:307
Cao et al. Journal of Translational Medicine
https://doi.org/10.1186/s12967-022-03502-8
Journal of
Translational Medicine
Open Access
RESEARCH
Extracellular vesicle miR‑32 derived
from macrophage promotes arterial calcification
in mice with type 2 diabetes via inhibiting VSMC
autophagy
Jingsong Cao1† , Cong Chen2†, Qian Chen1†, Yan Gao1, Zhibo Zhao1, Qing Yuan1, Anqi Li1, Shiqi Yang1,
Yuqi He2, Xuyu Zu3* and Jianghua Liu1*
Abstract
Background: The development of diabetes vascular calcification (VC) is tightly associated with the inhibition of
vascular smooth muscle cell (VSMC) autophagy. Previously, our team found that miR-32-5p (miR-32) promotes
macrophage activation, and miR-32 is expressed at higher level in the plasma of patients with coronary calcification.
However, whether miR-32 mediates the function of macrophages in type 2 diabetes (T2D) VC is still unclear.
Methods: Wild-type (WT) and miR-32−/− mice were used in this study. qRT-PCR and western blotting were used to
analyze gene expression. Flow cytometry was used to analyze the influence of glucose concentration on macrophage
polarization. Nanoparticle tracking analysis (NTA), transmission electron microscopy, and confocal microscopy were
used to identify macrophage extracellular vehicles (EVs). Immunofluorescence, in situ hybridization (ISH), immunohistochemistry, and alizarin red staining were used to analyze the influence of macrophage EVs on autophagy and
calcification of the aorta of miR-32−/− mice. A luciferase assay was used to analyze the effect of miR-32 on myocyte
enhancer factor 2D (Mef2d) expression. Co-IP combined with mass spectrometry (MS) and transcriptome sequencing
was used to analyze the signalling pathway by which Mef2d acts in VSMC autophagy.
Results: We found that high glucose conditions upregulate miR-32 expression in macrophages and their EVs.
Importantly, macrophages and their EVs promote VSMC osteogenic differentiation and upregulate miR-32 expression in VSMCs. Moreover, miR-32 mimics transfection promoted osteogenic differentiation and inhibited autophagy
in VSMCs. In vitro and in vivo experiments showed that Mef2d is the key target gene of miR-32 that inhibits VSMC
autophagy. Furthermore, MS and transcriptome sequencing found that cGMP-PKG is an important signalling pathway
by which Mef2d regulates VSMC autophagy. In addition, after T2D miR-32−/− mice were injected with macrophage
†
Jingsong Cao, Cong Chen, and Qian Chen are contributed equally to this
work.
*Correspondence: ;
1
The First Affiliated Hospital, Institute of Clinical Medicine, Department
of Endocrinology and Metabolism, Hengyang Medical School, University
of South China, Hengyang 421000, Hunan, China
3
The First Affiliated Hospital, Institute of Clinical Medicine, Department
of Tumor Research, Hengyang Medical School, University of South China,
Hengyang 421000, China
Full list of author information is available at the end of the article
© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco
mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Cao et al. Journal of Translational Medicine
(2022) 20:307
Page 2 of 15
EVs via the caudal vein, miR-32 was detected in aortic VSMCs of miR-32−/− mice. Moreover, autophagy was significantly inhibited, and calcification was significantly enhanced in aorta cells.
Conclusions: These results reveal that EVs are the key pathway by which macrophages promote T2D VC, and that
EVs miR-32 is a key cause of autophagy inhibition in VSMCs.
Keywords: Macrophage, EVs, miR-32, Diabetes, Vascular calcification
Introduction
Diabetes easily induces microvascular and macrovascular
complications that lead to peripheral vascular disease [1].
Vascular calcification (VC) is an important clinicopathological feature of diabetes and is considered as a major
independent risk factor for cardiovascular diseases [2].
In the process of VC, at least 4 kinds of cells may lead
to VC. These cell types include pericytes in microvessels,
pericyte-like calcifying vascular cells in the aortic intima,
smooth muscle cells (SMCs) in the media, and myofibroblasts in the adventitia [3]. Among the 4 cell types, local
smooth muscle cells are an important source of calcifying vascular cells [3–5]. The key to VSMC calcification
is the transformation from a contractile phenotype to an
osteoblast-like phenotype [6]. However, the mechanism
of VSMC calcification is still unclear.
Our previous research determined that the expression
of miR-32 is increased in VSMCs during the progression
of vascular calcification, and miR-32 was expressed at high
level in the plasma of VC patients compared with non-VC
patients [7]. Interestingly, we further found that miR-32 is
also involved in the activation of microglia, which are resident macrophages in the central nervous system [8]. Therefore, exploring the relationship and mechanisms among
macrophages, miR-32 and VSMC calcification is meaningful.
Macrophages are the major participators of innate
immunity and exist in all human tissues, including
the aortic wall [9]. In response to infection, peripheral
monocytes, derived from the bone marrow, are the
major source of macrophages in the aortic wall [10]. In
the plaques of human and mouse models, macrophages
are abundant immune cells, and they are the primary
cell type among total plaque cells [11, 12]. Infiltrated
macrophages polarize to the proinflammatory M1 phenotype and secrete inflammatory factors and exosomes,
leading to increased plaque stability [13, 14]. Macrophage polarization is a response to environmental
stimulation and involves coordinated metabolic and
transcriptional rewiring [15]. In diabetes, high glucose
induces M1 macrophage polarization and the secretion of exosomes to regulate the development of cardiovascular diseases [16, 17]. Recent research found
that the exosomes recovered by centrifugation include
oncosomes, ectosomes, microvesicles and membrane
vesicles, so the production is better called EVs [18].
However, the roles of macrophag (...truncated)